Wendy Osborne
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 8
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 10
- Oncology top 10%
- CAR-T cell therapy research 16
- Colorectal Cancer Surgical Treatments 6
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 19
- Rheumatology top 10%
-
- Stoma care and complications 9
- Diverticular Disease and Complications 4
-
- Biosimilars and Bioanalytical Methods 5
- Co-authors
- Jenny ByrneLetizia ForoniMhairi CoplandJane F. ApperleyDragana MilojkovićRichard E. ClarkHugues de LavalladeChristopher Pocock
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Wendy Osborne
40 papers receiving 597 citations
Peers
Comparison fields: 5 of 53
- Hematology 221
- Genetics 189
- Oncology 342
- Pathology and Forensic Medicine 149
- Rheumatology 101
Countries citing papers authored by Wendy Osborne
This map shows the geographic impact of Wendy Osborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Osborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Osborne more than expected).
Fields of papers citing papers by Wendy Osborne
This network shows the impact of papers produced by Wendy Osborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Osborne. The network helps show where Wendy Osborne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wendy Osborne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 64 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 9 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 15 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 22 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 116 | |
| 16 | 2019 | 0 | |
| 17 | 2018 | 10 | |
| 18 | 2014 | 24 | |
| 19 | 2004 | 8 | |
| 20 | 2004 | 6 |
About Wendy Osborne
Wendy Osborne is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 46 papers that have together received 608 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), CAR-T cell therapy research (16 papers), Chronic Lymphocytic Leukemia Research (10 papers), Stoma care and complications (9 papers), Chronic Myeloid Leukemia Treatments (8 papers), Colorectal Cancer Surgical Treatments (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Diverticular Disease and Complications (4 papers). The work is most often cited by research in Hematology (221 citations), Genetics (189 citations) and Oncology (342 citations). Wendy Osborne has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Jenny Byrne, Letizia Foroni, Mhairi Copland, Jane F. Apperley, Dragana Milojković, Richard E. Clark, Hugues de Lavallade, Christopher Pocock, Stephen G. O’Brien and Maria A. V. Marzolini. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.